Reproducibility remains a foundational principle of trustworthy science, yet reproducible research practices are still not consistently implemented across biomedical research, according to a new review published in Nature Medicine. The review maps the current landscape of reproducibility efforts, including attempts to harmonize terminology and implementation, the barriers that persist, and the responses emerging from the research ecosystem.
The review, published online on 29 September 2026, describes a field in which the value of reproducibility is broadly accepted but the practical application of reproducible methods varies widely. That gap between principle and practice is the central concern of the analysis, which synthesizes the state of reproducibility across biomedical research rather than focusing on a single study or institution.
One area the review highlights is the ongoing effort to harmonize terminology. Different researchers, journals, and institutions often use terms such as reproducibility, replicability, and repeatability in overlapping or inconsistent ways, which complicates both communication and the design of policies meant to enforce or encourage reproducible practices. Aligning that vocabulary is presented as a prerequisite for measuring progress and for comparing results across studies and fields.
Implementation is a separate challenge. Even where definitions are agreed upon, the review notes that reproducible research practices are not consistently put into effect. This inconsistency spans the biomedical research ecosystem, from how studies are designed and documented to how data and methods are shared and how findings are evaluated after publication.
The review also catalogs persistent barriers that stand in the way of broader adoption. These obstacles are described as enduring features of the research environment rather than isolated problems, which helps explain why reproducibility has improved in some areas while lagging in others. The analysis frames these barriers as structural, affecting researchers, institutions, publishers, and funders alike.
In response, the review points to ecosystem responses — coordinated efforts across the scientific community to address reproducibility shortfalls. These responses include work to standardize expectations, to support researchers in adopting reproducible methods, and to build infrastructure that makes reproducible practices easier to follow. The review presents these responses as part of a broader movement to make reproducibility a routine part of biomedical research rather than an optional add-on.
For readers of Science Official, the significance extends beyond methodology. Reproducibility underpins the reliability of medical evidence, which in turn shapes clinical guidelines, public health decisions, and patient care. When reproducible practices are applied inconsistently, the consequences can reach from the laboratory to the clinic, affecting how quickly and confidently findings can be translated into treatments and policies.
The review does not claim that the problem is solved. Instead, it summarizes a landscape in which progress is real but uneven, and in which the scientific community continues to negotiate how best to define, implement, and sustain reproducible research. By bringing together terminology efforts, persistent barriers, and ecosystem responses in one analysis, the review offers a consolidated view of where biomedical reproducibility stands and what remains to be done.
The publication of the review in Nature Medicine places the discussion within the mainstream of biomedical literature, signaling that reproducibility is treated as a core concern for the field rather than a niche methodological debate. For researchers, the message is that reproducible practices are increasingly expected, even as the tools and standards for implementing them continue to evolve.
15
